These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10085718)

  • 1. [Amiodarone and the thyroid gland].
    Modlinska A; Sworczak K
    Pol Arch Med Wewn; 1998 Jul; 100(1):74-81. PubMed ID: 10085718
    [No Abstract]   [Full Text] [Related]  

  • 2. The paradox of treating thyrotoxicosis with amiodarone.
    Unger J
    Eur J Med; 1993 May; 2(5):289-95. PubMed ID: 8252161
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone and the thyroid: pharmacological, toxic and therapeutic effects.
    Unger J; Lambert M; Jonckheer MH; Denayer P
    J Intern Med; 1993 Jun; 233(6):435-43. PubMed ID: 8501416
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzofuran derivatives and the thyroid.
    Han TS; Williams GR; Vanderpump MP
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):2-13. PubMed ID: 18727707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amiodarone and the thyroid].
    Martino E; Bartalena L; Bogazzi F; Brogioni S; Aghini-Lombardi F; Manetti L; Tanda ML
    Cardiologia; 1995 Dec; 40(12 Suppl 1):173-8. PubMed ID: 8998711
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid gland: use of glucocorticoids in amiodarone-induced thyrotoxicosis.
    Vanderpump MP
    Nat Rev Endocrinol; 2009 Dec; 5(12):650-1. PubMed ID: 19924150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kordaron and functional disorders of the thyroid gland].
    Zykova TA; Miroliubova OA; Kyrkalova NE; Mileĭko OS; Tkachev AV
    Klin Med (Mosk); 1991 Jun; 69(6):67-9. PubMed ID: 1774917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiodarone: pharmacology, clinical use and side effects].
    Popiliev I
    Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs affecting thyroid--part II].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Oct; 21(124):367-71. PubMed ID: 17205780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].
    Gómez JJ; Pomar MD; Casariego AV; Rodríguez IC
    Endocrinol Nutr; 2009 Oct; 56(8):418-21. PubMed ID: 19959152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone induced thyroid dysfunction: pathophysiology, diagnosis and management.
    Sandhu RS; Davies PH
    Adverse Drug React Toxicol Rev; 2001 Jun; 20(2):105-16. PubMed ID: 11481999
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in understanding the pharmacology of amiodarone.
    Nattel S; Talajic M
    Drugs; 1988 Aug; 36(2):121-31. PubMed ID: 2460307
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of amiodarone on thyroid hormone economy.
    Posner J; Sobel RJ; Glick S
    Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of amiodarone].
    Marmo E
    Arch Maragliano Patol Clin; 1974; 30(2):37-80. PubMed ID: 4283502
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone and the thyroid.
    Gammage MD; Franklyn JA
    Q J Med; 1987 Feb; 62(238):83-6. PubMed ID: 3310068
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles.
    Yamazaki K; Mitsuhashi T; Yamada E; Yamada T; Kosaka S; Takano K; Obara T; Sato K
    Thyroid; 2007 Dec; 17(12):1189-200. PubMed ID: 18020914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perchlorate and the thyroid gland.
    Wolff J
    Pharmacol Rev; 1998 Mar; 50(1):89-105. PubMed ID: 9549759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo.
    Brennan MD; Erickson DZ; Carney JA; Bahn RS
    Thyroid; 1995 Jun; 5(3):177-83. PubMed ID: 7580265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical procedure in amiodarone-induced thyroid dysfunction].
    Różycka-Kosmalska M; Michalak R; Kosmalski M; Ptaszyński P; Wranicz JK; Zieleniewski W; Cygankiewicz I
    Pol Merkur Lekarski; 2016 Jan; 40(235):46-52. PubMed ID: 26891437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.